Table 2 Sensitivity of MCA (*≥11 or **≥15 U/mL cut-off values)-CA15.3 and CEA-TPA-CA15.3 panels in the early detection of 19 relapses during an intensive post-operative follow-up with tumour markers.
| CE or PI of tumour markers as the initial pathological finding of relapse | |||||
|---|---|---|---|---|---|
| Tumour marker association |
aRelapses (total, n) |
Sensitivity (%) | Tumour marker increase |
Lead time (months) m + sd (range) | |
| type | n | ||||
| *MCA-CA15.3 | 13 | 68 |
CE PI | 8 5 |
7.1 ± 6.8 (0–22) |
| CEA-TPA-CA15.3 | 10 | 53 |
CE PI | 5 5 |
3.9 ± 4.9 (0–14) |
| **MCA-CA15.3 | 11 | 58 |
CE PI | 8 3 |
5.9 ± 6.7 (0–18) |
| CEA-TPA-CA15.3 | 14 | 74 |
CE PI | 8 6 |
4.6 ± 5.9 (0–18) |